It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Thomas J. Nielsen, MD

Patient Feedback
Specialty:
  • Otolaryngology
Board Certification:
  • Otolaryngology
Faculty Rank: Assistant Professor
Medical or Graduate Education: Rush Medical College
Residency: Rush University Medical Center - Otolaryngology
Clinical Expertise:
  • Airway disorders, pediatric
  • Bronchoscopy
  • Bronchoscopy, pediatric
  • Goiter
  • Head and neck surgery
  • Head and neck tumors
  • Hearing loss
  • Laryngeal surgery
  • Nasal and sinus disorders, pediatric
  • Nasal and sinus surgery
  • Sleep apnea
  • Thyroid surgery
  • Tonsillectomy
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing.
    Dandekar V, Morgan T, Turian J, Fidler MJ, Showel J, Nielsen T, Coleman J, Diaz A, Sher DJ
    Oral Oncol.
    2014 May
    50(5):520-6.
  2. Accumulation of nano-sized particles in a murine model of angiogenesis.
    Wittenborn TR, Larsen EK, Nielsen T, Rydtoft LM, Hansen L, Nygaard JV, Vorup-Jensen T, Kjems J, Horsman MR, Nielsen NC
    Biochem. Biophys. Res. Commun.
    2014 Jan 10
    443(2):470-6.
  3. Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer.
    Kallehauge JF, Tanderup K, Duan C, Haack S, Pedersen EM, Lindegaard JC, Fokdal LU, Mohamed SM, Nielsen T
    Acta Oncol
    2014 Aug
    53(8):1064-72.
  4. A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.
    Bohn AB, Wittenborn T, Brems-Eskildsen AS, Laurberg T, Bertelsen LB, Nielsen T, Stødkilde-Jørgensen H, Møller BK, Horsman MR
    PLoS ONE
    2014
    9(10):e110091.
  5. The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis.
    Ostergaard L, Tietze A, Nielsen T, Drasbek KR, Mouridsen K, Jespersen SN, Horsman MR
    Cancer Res.
    2013 Sep 15
    73(18):5618-24.
  6. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J, Nielsen T, Haack S, Peters DA, Mohamed S, Fokdal L, Lindegaard JC, Hansen DC, Rasmussen F, Tanderup K, Pedersen EM
    Acta Oncol
    2013 Oct
    52(7):1360-8.
  7. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia.
    Nielsen T, Nielsen NC, Holm TH, Ostergaard L, Horsman MR, Busk M
    Acta Oncol
    2013 Oct
    52(7):1287-92.
  8. Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model.
    Pamboukian SV, Tallaj JA, Brown RN, Nielsen T, George JF, Kirklin JK, Holman WL, Levy WC
    ASAIO J.
    2012 Mar-Apr
    58(2):93-7.
  9. Ultrahigh-field DCE-MRI of angiogenesis in a novel angiogenesis mouse model.
    Wittenborn T, Nielsen T, Nygaard JV, Larsen EK, Thim T, Rydtoft LM, Vorup-Jensen T, Kjems J, Nielsen NC, Horsman MR, Falk E
    J Magn Reson Imaging
    2012 Mar
    35(3):703-10.
  10. Combretastatin A-4 phosphate affects tumor vessel volume and size distribution as assessed using MRI-based vessel size imaging.
    Nielsen T, Bentzen L, Pedersen M, Tramm T, Rijken PF, Bussink J, Horsman MR, Østergaard L
    Clin. Cancer Res.
    2012 Dec 1
    18(23):6469-77.
  11. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
    Larsen EK, Nielsen T, Wittenborn T, Rydtoft LM, Lokanathan AR, Hansen L, Østergaard L, Kingshott P, Howard KA, Besenbacher F, Nielsen NC, Kjems J
    Nanoscale
    2012 Apr 7
    4(7):2352-61.
  12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.
    Nielsen T, Wittenborn T, Horsman MR
    Pharmaceutics
    2012
    4(4):563-89.
  13. Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation.
    Bertelsen LB, Shen YY, Nielsen T, Stødkilde-Jørgensen H, Lloyd GK, Siemann DW, Horsman MR
    Int. J. Radiat. Biol.
    2011 Nov
    87(11):1126-34.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
236
Friendliness/courtesy of the care provider
4.9
Explanations the care provider gave you about your problem or condition
4.9
Concern the care provider showed for your questions or worries
4.8
Likelihood of your recommending this care provider to others
4.9
Care provider's efforts to include you in decisions about your treatment
4.8
Information the care provider gave you about medications
4.8
Instructions the care provider gave you about follow-up care
4.9
Your confidence in this care provider
4.9
Degree to which care provider talked with you using words you could understand
4.9
Amount of time the care provider spent with you
4.8
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.